Cytogel Pharma LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cytogel Pharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10539
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cytogel Pharma LLC (Cytogel Pharma) is a biopharmaceutical development company that provides platform technologies and product candidates. The company offers novel analgesic product candidates and polymer and hydrogel drug delivery platform technologies. Its analgesic product candidates offer the control of various pain models. Cytogel Pharma provides pain relief and polymer systems used for making biological drugs. The company’s drug delivery technologies are used in various applications in human pharmaceuticals, medical devices and animal health pharmaceuticals. The company licenses its products to other larger companies for the full scientific and clinical development and subsequent commercialization. It caters pain management and drug dilevery sectors. Cytogel Pharma is headquartered in Darien, Connecticut, the US.

Cytogel Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cytogel Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cytogel Pharma Raises USD0.2 Million in Venture Financing 10
Cytogel Pharma Raises USD2.7 Million in Venture Financing 11
Cytogel Pharma Raises US$0.24 Million In Venture Financing 12
Cytogel Pharma Raises US$0.75 Million In Venture Financing 13
Cytogel Pharma LLC – Key Competitors 14
Cytogel Pharma LLC – Key Employees 15
Cytogel Pharma LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Key Facts 2
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cytogel Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cytogel Pharma LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cytogel Pharma Raises USD0.2 Million in Venture Financing 10
Cytogel Pharma Raises USD2.7 Million in Venture Financing 11
Cytogel Pharma Raises US$0.24 Million In Venture Financing 12
Cytogel Pharma Raises US$0.75 Million In Venture Financing 13
Cytogel Pharma LLC, Key Competitors 14
Cytogel Pharma LLC, Key Employees 15

List of Figures
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cytogel Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cytogel Pharma LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Sinar Mas Multiartha Tbk (SMMA):企業の財務・戦略的SWOT分析
    PT Sinar Mas Multiartha Tbk (SMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Atea ASA (ATEA):企業の財務・戦略的SWOT分析
    Atea ASA (ATEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PTC Inc (PTC):企業の財務・戦略的SWOT分析
    PTC Inc (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • Aker Solutions ASA:企業の戦略・SWOT・財務分析
    Aker Solutions ASA - Strategy, SWOT and Corporate Finance Report Summary Aker Solutions ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Glenmark Pharmaceuticals Limited:企業のM&A・事業提携・投資動向
    Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Essar Power Limited:発電所・企業SWOT分析
    Essar Power Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive assessment company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. Its clinical trail solutions include computerized cognitive assessment, cogstate prescreen, …
  • Phytel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phytel Inc (Phytel), a subsidiary of International Business Machines Corporation is an integrated population health management software and solutions provider. The company’s services include reduce total cost of care, prepare for value based care, increase patient engagement, measure quality …
  • StormGeo AS:石油・ガス:M&Aディール及び事業提携情報
    Summary StormGeo AS (StormGeo) is a weather forecast company that offers professional weather services and decision support for weather sensitive operations. The company operates through segments that include shipping, oil and gas, marine operations, renewable, aviation, cross industry and media. It …
  • Valeritas Inc:医療機器:M&Aディール及び事業提携情報
    Summary Valeritas Inc (Valeritas) is a medical technology company that develops and commercializes treatment solutions for diabetes. The company’s product includes V-Go insulin delivery device a wearable basal-bolus insulin delivery solution for patients with Type 2 diabetes. It also provides V-Go l …
  • Lumenis Ltd:企業の戦略的SWOT分析
    Lumenis Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Aggreko Plc (AGK)-エネルギー分野:企業M&A・提携分析
    Summary Aggreko plc (Aggreko) is a provider of power generation and industrial heating and cooling solutions. It produces power; installs and operates modular and mobile power plants; and develops and rents electric solutions and equipment. The company offers range of diesel and gas power generators …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Enel SpA:企業の戦略・SWOT・財務情報
    Enel SpA - Strategy, SWOT and Corporate Finance Report Summary Enel SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Elasmogen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd, is a biopharmaceutical company which focuses on the development of soloMER products for the treatment of auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical can …
  • Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentra …
  • Acorda Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Acorda Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acorda Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆